Chronic headache. Chronic migraine with daily headache (literature review)

28 березня 2024
285
УДК:  616.857
Спеціальності :
Резюме

The article identifies common etiological factors of chronic headache, outlines the main clinical features of its various types. Similarities and differences between chronic tension-type headache and chronic migraine were studied, and a group of patients with chronic migraine who experienced daily headaches were characterized. Patients with daily headache may account for up to ⅓ of all patients with chronic migraine and have specific clinical characteristics and more complex pathophysiological mechanisms leading to headache, with a different response to treatment.

References

  • 1. Levin M. (2022) Classification and Diagnosis of Primary Headache Disorders. Neurol., 42(4): 406–417. doi: 10.1055/a-1954-3937.
  • 2. Stovner L., Hagen K., Jensen R. et al. (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia, 27(3): 193–210.
  • 3. Onan D., Younis S., Wellsgatnik W.D. (2023) Debate: differences and similarities between tension-type headache and migraine. J. Headache Pain, 24(1): 92.
  • 4. Martínez-Pías E., García-Azorín D., Trigo-López J. (2021) Chronic migraine with daily headache. Literature review. Rev. Neurol., 72(4): 133–140.
  • 5. Robbins M.S., Lipton R.B. (2010) The epidemiology of primary headache disorders. Semin. Neurol., 30: 107–119. doi: 10.1055/s-0030-1249220.
  • 6. Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd ed. Cephalalgia, 38: 1–211.
  • 7. Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd ed. Cephalalgia, 33: 629–808.
  • 8. International Headache Society Classification Committee (1988) Сlassification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia, 8 (Suppl. 7): S1– S96.
  • 9. Su M., Yu S. (2018) Chronic migraine: a process of dysmodulation and sensitization. Mol. Pain, 14: 1744806918767697.
  • 10. Ashina S., Mitsikostas D.D., Lee M.J. et al. (2021) Tension-type headache. Nat. Rev. Dis. Primers., 7(1): 24.
  • 11. Begasse de Dhaem O., Rizzoli P. (2022) Refractory Headaches. Semin Neurol., 42(4): 512–522. doi: 10.1055/s-0042-1757925.
  • 12. Silberstein S.D., Lipton R.B. (2000) Chronic daily headache. Curr. Opin. Neurol., 13: 277–283. doi: 10.1097/00019052-200006000-00008.
  • 13. Diener H.C., Dodick D., Evers S. (2019) Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol.,18(9): 891–902.
  • 14. Singh R.K., Goel D., Kaushik R. (2023) Association between iron deficiency anemia and chronic daily headache: A case-control study. Cephalalgia, 43(2): 3331024221143540.
  • 15. Ashina S., Bendtsen L., Buse D.C. et al. (2017) Neuroticism, depression and pain perception in migraine and tension-type headache. Acta Neurol Scand., 136(5): 470–476.
  • 16. Lampl Ch., Thomas H., Tassorelli C. et al. (2016) Headache, depression and anxiety: associations in the Eurolight project. J. Headache Pain, 17: 59.
  • 17. Ashina S., Bendtsen L., Lyngberg A.C. et al. (2015) Prevalence of neck pain in migraine and tension-type headache: a population study. Cephalalgia, 35(3): 211–219.
  • 18. Ashina S., Lipton R.B., Bendtsen L. et al. (2018) Increased pain sensitivity in migraine and tension-type headache coexistent with low back pain: A cross-sectional population study. Eur. J. Pain, 22(5): 904–914. doi: 10.1002/ejp.1176.
  • 19. Bigal M.E., Lipton R.B. (2006) Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology, 67(2): 252–257.
  • 20. Kim J., Cho S.-J., Kim W.-J. et al. (2018) Impact of migraine on the clinical presentation of insomnia: a population-based study. J. Headache Pain, 19(1): 86.
  • 21. Lipton R.B., Cady R.K., Stewart W.F. et al. (2002) Diagnostic lessons from the spectrum study. Neurology, 58(9 Suppl. 6): S27–S31. doi: 10.1212/WNL.58.9_suppl_6.S27.
  • 22. Headache Classification Subcommittee of the International Headache Society (2004) The International Clasiffication of Headache Disorders, 2nd ed. Cephalalgia, 24(Suppl. 1): S9–S160.
  • 23. Pascual J., Colás R., Castillo J. (2022) Epidemiology of chronic daily headache. Curr. Pain Headache, 5: 529–536. doi: 10.1007/s11916-001-0070-6.
  • 24. Gracia-Naya M., Alarcia-Alejos R., Modrego-Pardo P.J. (2008) Importancia de la migraña crónica en una consulta general de neurología. Rev. Neurol., 46: 577–581.
  • 25. Scher A.I., Stewart W.F., Liberman J. (1998) Prevalence of frequent headache in a population sample. Headache, 38: 497–506. doi: 10.1046/j.1526-4610.1998.3807497.x.
  • 26. Castillo J., Muñoz P., Guitera V. (1999) Epidemiology of chronic daily headache in the ge­neral population. Headache, 39: 190–196. doi: 10.1046/j.1526-4610.1999.3903190.x
  • 27. Lantéri-Minet M., Auray J.P., El Hasnaoui A. (2003) Prevalence and description of chronic daily headache in the general population in France. Pain, 102: 143–149.
  • 28. Queiroz L.P., Peres M.F., Kowacs F. (2008) Chronic daily headache in Brazil: a nationwide population-based study. Cephalalgia, 28: 1264–1269.
  • 29. Park J.W., Moon H.S., Kim J.M. (2014) Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management. J. Clin. Neurol., 10: 236–243. doi: 10.3988/jcn.2014.10.3.236.
  • 30. Lake A.E. 3rd. (2005) Chronic daily headache in the absence of medication overuse: is daily or continuous pain more treatment-resistant than chronic daily headache with pain-free days? Curr. Pain Headache, 9: 4–6. doi: 10.1007/s11916-005-0067-7.
  • 31. Blumenfeld A.M., Varon S.F., Wilcox T.K. (2011) Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia, 31: 301–315. doi: 10.1177/0333102410381145.
  • 32. Caronna E., Gallardo V.J., Hernández-Beltrán N. (2018) OnabotulinumtoxinA: an effective tool in the therapeutic arsenal for chronic migraine with medication overuse. Front. Neurol., 9: 808. doi: 10.3389/fneur.2018.00808.
  • 33. Young W.B., Ivan Lopez J., Rothrock J.F. (2019) Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study. J. Headache Pain, 20: 12. doi: 10.1186/s10194-018-0953-0.
  • 34. Rojo E., Pedraza M.I., Muñoz I. (2015) Chronic migraine with and without medication overuse: experience in a hospital series of 434 patients. Neurologia, 30: 153–157.
  • 35. Ong J.J.Y., De Felice M. (2018) Migraine treatment: current acute medications and their potential mechanisms of action. Neurotherapeutics, 15: 274–290.
  • 36. Seok J.I., Cho H.I., Chung C.S. (2006) From transformed migraine to episodic migraine: reversion factors. Headache, 46: 1186–1190. doi: 10.1111/j.1526-4610.2006.00509.x.